Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

CYTKCYTK
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in CYTOKINETICS INC

JPMORGAN CHASE & CO holds 1.6M shares of CYTK (CYTOKINETICS INC), worth $139.2M as of 2026-Q2. The position was increased (+75.8% shares). CYTK represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$139.2M

Current Shares

1.6M

Total Value Change

+$63M

Total Shares Change

-29,507

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+75.8%
$139.2M0.0%$85.19
46
2026-Q1
Decreased
903,805
-36.0%
$56.9M0.0%$65.91
0
2025-Q4
Decreased
1.4M
-54.2%
$89.8M0.0%$63.54
0
2025-Q3
Increased
3.1M
+134.2%
$169.6M0.0%$54.96
49
2025-Q2
Decreased
1.3M
-0.6%
$43.5M0.0%$33.04
0
2025-Q1
Decreased
1.3M
-18.1%
$53.3M0.0%$40.19
0
2024-Q4
New
1.6M
-
$76.1M0.0%$47.04
41

Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used